In December 2023, we published a revised edition of the Lexicon as an eBook, which includes updated entries for 104 of the most salient terms we have collected over the past 20 years. Please ...

Lexicon Pharmaceuticals, Inc.’s LXRX share price has dipped by 11.26%, which has investors questioning if this is right time ...

The M&A-focused Betaville blog sent an alert to subscribers highlighting a rumor regarding Lexicon (LXRX), contacts tell The Fly.Invest ...

Event will feature insights on LX9211, Lexicon’s novel, investigational, non-opioid treatment, as well as expert panel and Q&A session on DPNPTHE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE ...

THE WOODLANDS, Texas, Jan. 21, 2025 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) today announced that the company will host a virtual webcast: “LX9211 - Changing the Paradigm for ...

Lexicon also announced it had entered into an agreement to privately place $250M of its stock by offering approximately 2.3M shares of its series A convertible preferred stock at $108.50 per share ...

Leerink Partners analyst Roanna Ruiz has maintained their bullish stance on LXRX stock, giving a Buy rating yesterday.Invest with Confidence: ...

Their "New lexicon for the age of microbiome research," which redefines a large number of fundamental life science terms and ...